No abstract

Objective: The aim of the study is to evaluate the analgesic and anti-inflammatory activities of the ethanolic extract of Punica granatum L. (EEPG) on experimental animal models. Methods: Tail-flick method was used to test the central analgesic activity, using Pethidine as standard drug. The tail flick latencies or the basal reaction time of the animals were assessed using an analgesiometer. Glacial acetic acid induced writhing response was used to test the peripheral analgesic activity, using Aspirin as standard drug. Number of writhing responses was counted for 20 min in each group and the percentage protection was calculated. And Carrageenan induced rat paw edema method was used to test anti-inflammatory activity of EEPG against acute inflammation, using Aspirin as standard drug. The inhibition of rat paw edema was calculated in percentage. Results: In central analgesic activity, the extract and pethidine showed significant increase in the reaction time. In peripheral analgesic activity, the extract and aspirin significantly reduced the number of writhes induced by acetic acid. And in anti-inflammatory activity, the extract produced significant reduction of the carrageenan induced paw edema. Conclusion: The EEPG has demonstrated significant analgesic and anti-inflammatory activity.

DIAGNOSISThe diagnosis of BD is generally based on clinical signs and symptoms of the patient. A detailed history and thorough physical as well as mental status examination is essential for the diagnosis. More often, it is necessary to collect the patient's behavioral history from family members and ABSTRACT Bipolar disorder (BD) is a chronic disorder which usually has its onset in early adulthood. At one end of the spectrum is depression and at other is mania. Like many psychiatric illnesses, it is not treatable but its symptoms are completely manageable with medications. Commonly used drugs are mood stabilizers and atypical antipsychotics along with adjunctive medications such as anxiolytics and antidepressants. In general, a combination of these drugs is used for treatment. These drugs have significant adverse effects which add to the burden of the disease. Presently, there are 11 US Food and Drug Administration -approved drugs for management of acute mania, 3 for bipolar depression and 7 for bipolar maintenance. This review article details the use of these drugs in BD.

Background: Hydroxychloroquine (HCQ) has been extensively used during COVID-19 pandemic both as a therapeutic and prophylactic drug. HCQ is generally well tolerated; however, adverse drug reactions (ADRs) in COVID-19 need further exploration. In this study, we have determined the type and pattern of ADRs of HCQ as a prophylactic and therapeutic drug in COVID-19. Methods: All spontaneous suspected ADR reports due to HCQ in COVID-19 patients submitted to the ADR monitoring of a tertiary care hospital were included. Additionally, a survey was designed for active surveillance of ADRs among healthcare professionals (HCPs) who were on prophylaxis with HCQ. The ADRs were analyzed to determine severity, causality and preventability using Hartwig Scale, WHO-UMC scale and modified Schumock and Thornton criterion respectively. Results: Sixty-four ADR reports were received from COVID-19 patients. A total of 78 ADRs were reported by 49 HCPs who were on HCQ prophylaxis. The majority of the patients had ADRs related to skin and soft tissues (37.5 %) whereas the HCPs on prophylaxis mostly had gastrointestinal complaints (42.3%). ADRs observed in HCPs on prophylaxis were mild, not requiring any intervention. However, 50% ADRs in patients were of “moderate” category. Conclusion: Undiscerning and unsupervised use of HCQ can expose the general population as well as patients to serious adverse drug effects. Utmost care is necessary before using HCQ prophylactically or for treatment in COVID-19.

Objective: The aim of the study is to evaluate hypoglycemic action of Ethanolic extract of leaves of Oxalis corniculata linn. on normal and Alloxan-induced diabetic albino rats.   Methods: Hyperglycemia is induced by use of intraperitoneal injection of Alloxan and Adrenaline. After that test drug Ethanolic extract of leaves of Oxalis corniculata (ELOC) and standard drug Glibenclamide in administered. The hypoglycemic effect of ELOC is compared with the standard drug and control.   Results: Significant hypoglycemic activity of ELOC was seen in Alloxan induced hyperglycemia when blood glucose levels were estimated from different tissues. Also, significant hypoglycemic activity of ELOC was seen in Adrenaline induced hyperglycemia.   Conclusion: Ethanolic extract of leaves of Oxalis corniculata (ELOC) possess hypoglycemic activity. Key words: hypoglycemic activity, Alloxan, Oxalis corniculata